Development of a Culturally Adapted Digital Health Application for Older Hispanics with Type 2 Diabetes
Project Number1R21DK139557-01
Contact PI/Project LeaderCABALLERO, JOSHUA
Awardee OrganizationUNIVERSITY OF GEORGIA
Description
Abstract Text
PROJECT SUMMARY
Poor health literacy, medication non-adherence, and lack of interventions easily delivered by healthcare
providers negatively impact health outcomes in Hispanic patients with type 2 diabetes (T2D). Hispanics use
smartphones, download apps, and search online for health-related information more often than other groups in
the U.S.; however, health information found online and in existing digital apps can be misleading, difficult to
interpret, and is seldom individually tailored. A digital health app with individually tailored educational content
which is useable, engaging, and culturally adapted would likely improve comprehensive medication
management (CMM) delivery to older Hispanics with T2D by improving their understanding of the disease and
medications, and ultimately improve their health outcomes. The proposed project’s goal is therefore to
create a digital health app that will empower older Hispanics with T2D to manage their disease.
Through previous funding, we developed a computer-delivered, individually-tailored, and culturally adapted
prototype health intervention consisting of three modules which target health literacy and aim to improve
adherence in older Hispanics with T2D. During preliminary testing, patients agreed that the modules were easy
to use, culturally appropriate, and relevant to their needs, while pharmacists agreed that the intervention could
streamline patient counseling and offered a tailored approach to provide CMM. In this proposal, we will
transform the prototype content into a modernized digital health app aimed at maximizing CMM in this patient
population by improving health literacy and medication adherence. Based on the preliminary testing, we
hypothesize that this digital health app will be useable and accepted by both the patients and their
pharmacists, and will improve medication adherence, hemoglobin A1c, and fasting glucose levels.
Our proposal consists of two Specific Aims: 1) to refine and modernize previously developed health
intervention content and develop a digital health app for older Hispanic patients with T2D and their pharmacists
that is usable and accepted; and 2) to assess health outcomes by pilot testing the app in 40 Hispanic adults 50
years or older with T2D. The long-term goal is to create a digital health app to educate patients by
providing critical, individually tailored information in a secure format that is easy to use, cost-effective
and which will enable pharmacists to provide patient-tailored CMM. Following completion of the proposed
project, the refined digital health app will be ready for wider dissemination and testing in a larger-scale study.
Our team will also be prepared to conduct a large scale, robust, and pragmatic trial of the integration of the
digital health app into pharmacist patient care services to improve T2D medication use and health outcomes.
The results of this project will not only lead to a sustained, powerful influence on managing T2D, but will also
provide a foundational framework for ubiquitous application to different diseases, languages, and cultures that
can be leveraged by various healthcare providers to provide CMM in a systematic and efficient manner.
Public Health Relevance Statement
PROJECT NARRATIVE
Currently, 41% of Hispanics (34.2 million persons) have below basic health literacy (HL) levels, and, when
combined with multiple burdens of chronic diseases such as type 2 diabetes (T2D), this negatively impacts
adherence to treatment. The goal of the proposed project is to create a culturally adapted digital health app
that will empower older Hispanics with T2D to improve medication adherence and manage their illness by
providing tailored, accurate information on T2D, self-management options, and knowledge on prescribed
medications while directly involving pharmacists providing them comprehensive medication management. The
results of this project will not only lead to a sustained, powerful influence on T2D management, but will also
provide a foundational framework for ubiquitous application to different diseases, languages, and cultures that
can be leveraged by various healthcare providers to provide comprehensive medication management in a
systematic and efficient manner.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdherenceAdultAgeAge YearsAgreementCaringCellular PhoneChronic DiseaseClinicalClinical PharmacistsComputersCounselingDataDevelopmentDiabetes MellitusDiseaseDisparity populationDrug PrescriptionsEducationEnsureEthnic OriginFederally Qualified Health CenterFeedbackFundingGlycosylated hemoglobin AGoalsHealthHealth Care CostsHealth PersonnelHealth Services AccessibilityHealthcareHispanicHispanic PopulationsHospitalizationImpairmentIndividualInterventionKnowledgeLanguageLeadMeasuresMedication ManagementMental HealthMethodsModelingModernizationNeighborhood Health CenterNon-Insulin-Dependent Diabetes MellitusNot Hispanic or LatinoOutcomeOutpatientsParticipantPatient CarePatient MonitoringPatient RecruitmentsPatientsPersonsPharmaceutical PreparationsPharmacistsRaceReportingRoleSecureSelf ManagementSystemTechnologyTestingTimeUnited States National Institutes of HealthVisitbarrier to careburden of chronic illnesscare systemscost effectiveculturally appropriate interventiondiabetes managementdigitaldigital applicationsdigital healthdigital technologyempowermentfasting glucosefollow-uphealth applicationhealth assessmenthealth literacyimprovedlow health literacymedication compliancemedication nonadherenceminority patientpatient populationpersonalized approachpilot testpragmatic trialprototypeskillssuccesstreatment adherencetreatment planningusability
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
004315578
UEI
NMJHD63STRC5
Project Start Date
20-September-2024
Project End Date
31-August-2027
Budget Start Date
20-September-2024
Budget End Date
31-August-2025
Project Funding Information for 2024
Total Funding
$188,104
Direct Costs
$125,000
Indirect Costs
$63,104
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Diabetes and Digestive and Kidney Diseases
$188,104
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R21DK139557-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R21DK139557-01
Patents
No Patents information available for 1R21DK139557-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R21DK139557-01
Clinical Studies
No Clinical Studies information available for 1R21DK139557-01
News and More
Related News Releases
No news release information available for 1R21DK139557-01
History
No Historical information available for 1R21DK139557-01
Similar Projects
No Similar Projects information available for 1R21DK139557-01